Related Experiment Video
Updated: Apr 19, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.1K
Multi-modality canonical feature selection for Alzheimer's disease diagnosis
Summary
This study introduces a new method for selecting features from multiple medical imaging types, improving analysis of high-dimensional data. The approach enhances accuracy in predicting Alzheimer's disease progression and diagnosis.
Area of Science:
- Medical Image Analysis
- Machine Learning
- Biostatistics
Background:
- High-dimensional medical imaging data presents challenges like the curse of dimensionality.
- Existing feature selection methods often overlook cross-modality feature correlations.
Purpose of the Study:
- To propose a novel multimodality canonical feature selection method.
- To enhance feature selection by incorporating cross-modality correlations.
- To improve clinical score prediction and disease identification in Alzheimer's disease.
Main Methods:
- Developed a multimodality canonical feature selection framework.
- Utilized canonical correlation analysis to project features into a canonical space.
- Employed sparse least squares regression with a novel canonical regularizer.
Main Results:
- The proposed method effectively selects canonical-cross-modality features.
- Demonstrated utility in predicting Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) and Mini-Mental State Examination (MMSE) scores.
- Showed success in multiclass disease identification for Alzheimer's disease diagnosis.
Conclusions:
- The novel method advances feature selection for multimodality medical imaging.
- This approach offers improved performance for Alzheimer's disease clinical prediction and diagnosis.
- The technique effectively leverages complementary information from different imaging modalities.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer Disease l: Introduction
4
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
4
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease ll: Pathophysiology
2
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
Dementia l: Introduction
3
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
3

